Screening tools interventions and strategies for early identification and management of autism spectrum disorders
Keywords:Autism, Spectrum, Disorder, Children, Screening
Autism spectrum disorder is a neurodevelopmental disorder marked by social communication difficulties, restricted interests, and repetitive activities. Both genetic and environmental variables impacting the growing brain influence it. Around the world, 1 in 100 children is identified with autism spectrum disorder. Estimates of prevalence have increased over time and varied significantly inside and across sociodemographic groups. Autism spectrum disorder is a prevalent neurodevelopmental condition that significantly shortens life expectancy. Early diagnosis on a community level is a critical public health concern since mounting evidence shows that early diagnosis makes functional gains and has better outcomes. In healthcare settings, autism spectrum disorder screening tools can be utilized to precisely confirm the diagnosis of autism. The American Academy of Pediatrics recommends screening for ASDs between ages 18 and 24 months, although recent research indicates that abnormal behaviours may be visible in certain children even earlier. the checklist for autism in toddlers, the modified checklist for autism in toddlers, the psychological development questionnaire-1, and the autism behaviour checklist are some of the commonly used screening tools in practice for the diagnosis of autism spectrum disorder. The majority of interventions are non-pharmacological and depend on behavioural modification strategies. Pharmacological therapy should only be used to treat target symptoms that are resistant to behavioural treatment. Although there is no cure, prompt and suitable intervention can dramatically raise the quality of life for children. The purpose of this research is to review the screening tools, interventions, and strategies for early identification and management of autism spectrum disorder.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5, 2013. Available at: https://www.psychiatry.org/ psychiatrists/practice/dsm. Accessed on 22 August 2023.
Sharma SR, Gonda X, Tarazi FI. Autism Spectrum Disorder: Classification, diagnosis and therapy. Pharmacol Ther. 2018;190:91-104.
Bougeard C, Picarel-Blanchot F, Schmid R, Campbell R, Buitelaar J. Prevalence of Autism Spectrum Disorder and Co-morbidities in Children and Adolescents: A Systematic Literature Review. Front Psychiatry. 2021;12:744709.
Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: A systematic review update. Autism Res. 2022;15(5):778-90.
Zwaigenbaum L, Bauman ML, Choueiri R, Fein D, Kasari C, Pierce K, et al. Early Identification and Interventions for Autism Spectrum Disorder: Executive Summary. Pediatrics. 2015;136(1):S1-9.
Marlow M, Servili C, Tomlinson M. A review of screening tools for the identification of autism spectrum disorders and developmental delay in infants and young children: recommendations for use in low- and middle-income countries. Autism Res. 2019;12(2):176-99.
Myers SM, Johnson CP; American Academy of Pediatrics Council on Children With Disabilities. Management of children with autism spectrum disorders. Pediatrics. 2007;120(5):1162-82.
Salmon G, Cleave H, Samuel C. Development of multi-agency referral pathways for attention-deficit hyperactivity disorder, developmental coordination disorder and autistic spectrum disorders: reflections on the process and suggestions for new ways of working. Clin Child Psychol Psychiatry. 2006;11(1):63-81.
Tsang LPM, How CH, Yeleswarapu SP, Wong CM. Autism spectrum disorder: early identification and management in primary care. Singapore Med J. 2019;60(7):324-8.
Sobieski M, Sobieska A, Sekułowicz M, Bujnowska-Fedak MM. Tools for early screening of autism spectrum disorders in primary health care - a scoping review. BMC Prim Care. 2022;23(1):46.
Soto S, Linas K, Jacobstein D, Biel M, Migdal T, Anthony BJ. A review of cultural adaptations of screening tools for autism spectrum disorders. Autism. 2015;19(6):646-61.
Levy SE, Wolfe A, Coury D, Duby J, Farmer J, Schor E, et al. Screening Tools for Autism Spectrum Disorder in Primary Care: A Systematic Evidence Review. Pediatrics. 2020;145(1):S47-S59.
Hirota T, So R, Kim YS, Leventhal B, Epstein RA. A systematic review of screening tools in non-young children and adults for autism spectrum disorder. Res Dev Disabil. 2018;80:1-12.
Baird G, Charman T, Baron-Cohen S, Cox A, Swettenham J, Wheelwright S, et al. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2000;39(6):694-702.
Wetherby AM, Brosnan-Maddox S, Peace V, Newton L. Validation of the Infant-Toddler Checklist as a broadband screener for autism spectrum disorders from 9 to 24 months of age. Autism. 2008;12(5):487-511.
Zahorodny W, Shenouda J, Mehta U, Yee E, Garcia P, Rajan M, et al. Preliminary Evaluation of a Brief Autism Screener for Young Children. J Dev Behav Pediatr. 2018;39(3):183-91.
Thabtah F, Peebles D. Early Autism Screening: A Comprehensive Review. Int J Environ Res Public Health. 2019;16(18):3502.
Sappok T, Heinrich M, Underwood L. Screening tools for autism spectrum disorders. Adv Autism. 2015;1(1):12-29.
DeFilippis M, Wagner KD. Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacol Bull. 2016;46(2):18-41.
Mukherjee SB. Autism Spectrum Disorders - Diagnosis and Management. Indian J Pediatr. 2017;84(4):307-14.
Gadia CA, Tuchman RF. Management of children with autism spectrum disorders. Revista de neurologia. 2003;36(2):166-73.
Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics. 2022;19(1):248-62.
Baribeau D, Vorstman J, Anagnostou E. Novel treatments in autism spectrum disorder. Curr Opin Psychiatry. 2022;35(2):101-10.